Bill
Bill > A4677
NJ A4677
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.
summary
Introduced
06/28/2024
06/28/2024
In Committee
06/28/2024
06/28/2024
Crossed Over
Passed
Dead
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill increases the amount of cigarette and other tobacco products tax revenues provided to the New Jersey Commission on Cancer Research (NJCCR) to $10 million. The bill also establishes a dedicated, non-lapsing Cancer Research Fund within the Department of the Treasury. In doing so, the bill prioritizes funding: 1) to expand the NJCCR's capacity to fund research regarding the causes, prevention, treatment, and palliation of all cancers and to serve as a resource of information to providers and consumers of cancer care and treatment services; and 2) for cancer research grants that reduce and eliminate disparities among the various racial and ethnic populations within the State's minority and vulnerable communities by increasing access to clinical trials and high-quality cancer care and treatment. Pursuant to current statute, the NJCCR annually receives $1 million in cigarette and other tobacco products tax revenues. This money is deposited into an existing lapsing Cancer Research Fund and then appropriated to the commission. In recent years, pursuant to the annual appropriations act, this money has been transferred from the Cancer Research Fund to the General Fund. The appropriations act then provides the NJCCR funding via a budget line. Despite the statutory requirement, in FY 2024, the NJCCR was appropriated $4 million in funding. Under the bill, the existing lapsing Cancer Research Fund is replaced by a non-lapsing, revolving fund. This fund is to be the repository of the $10 million in cigarette and other tobacco products tax revenues deposited into the account under the bill and any other funds approved by the Department of Health or the NJCCR. Moneys deposited in the fund, and any interest earned thereon, are to be used exclusively for providing grants for cancer research projects authorized and approved by the commission, with at least $5 million to be used to fund general cancer research and at least $5 million to be used to fund pediatric cancer research. The State Treasurer will be the custodian of the fund and all disbursements from the fund are to be made by the State Treasurer upon vouchers signed by the chairperson of the NJCCR or the chairperson's designee. The monies in the fund are to be invested and reinvested by the Director of the Division of Investment in the Department of the Treasury in the same manner as other trust funds in the custody of the State Treasurer, in the manner provided by law. Interest received on the monies in the fund are to be credited to the fund.
AI Summary
This bill increases the amount of cigarette and other tobacco products tax revenues provided to the New Jersey Commission on Cancer Research (NJCCR) from $1 million to $10 million annually. It also establishes a dedicated, non-lapsing Cancer Research Fund within the Department of the Treasury to serve as the repository for these funds, which will be used exclusively for providing grants for general cancer research and pediatric cancer research projects authorized and approved by the NJCCR. The bill prioritizes funding to expand the NJCCR's capacity and to reduce disparities in access to clinical trials and high-quality cancer care among minority and vulnerable communities in the state.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 06/28/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A4677 |
BillText | https://pub.njleg.gov/Bills/2024/A5000/4677_I1.HTM |
Loading...